BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26279429)

  • 1. Impact of p38 MAP Kinase Inhibitors on LPS-Induced Release of TNF-α in Whole Blood and Primary Cells from Different Species.
    Fehr S; Unger A; Schaeffeler E; Herrmann S; Laufer S; Schwab M; Albrecht W
    Cell Physiol Biochem; 2015; 36(6):2237-49. PubMed ID: 26279429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DBM1285 suppresses tumor necrosis factor alpha production by blocking p38 mitogen-activated protein kinase/mitogen-activated protein kinase-activated protein kinase 2 signaling pathway.
    Kang JS; Kim HM; Choi IY; Han SB; Yoon YD; Lee H; Park KH; Cho IJ; Lee CW; Lee K; Lee KH; Park SK
    J Pharmacol Exp Ther; 2010 Aug; 334(2):657-64. PubMed ID: 20427474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of AW-814141, a novel, potent, selective and orally active inhibitor of p38 MAP kinase.
    Chopra P; Kulkarni O; Gupta S; Bajpai M; Kanoje V; Banerjee M; Bansal V; Visaga S; Chatterjee M; Chaira T; Shirumalla RK; Verma AK; Dastidar SG; Sharma G; Ray A
    Int Immunopharmacol; 2010 Apr; 10(4):467-73. PubMed ID: 20093202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pamapimod, a novel p38 mitogen-activated protein kinase inhibitor: preclinical analysis of efficacy and selectivity.
    Hill RJ; Dabbagh K; Phippard D; Li C; Suttmann RT; Welch M; Papp E; Song KW; Chang KC; Leaffer D; Kim YN; Roberts RT; Zabka TS; Aud D; Dal Porto J; Manning AM; Peng SL; Goldstein DM; Wong BR
    J Pharmacol Exp Ther; 2008 Dec; 327(3):610-9. PubMed ID: 18776065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of P38 MAPK and PKC in BLP induced TNF-alpha release, apoptosis, and NFkappaB activation in THP-1 monocyte cells.
    O'Sullivan AW; Wang JH; Redmond HP
    J Surg Res; 2009 Jan; 151(1):138-44. PubMed ID: 18675993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From Enzyme to Whole Blood: Sequential Screening Procedure for Identification and Evaluation of p38 MAPK Inhibitors.
    Bauer SM; Kubiak JM; Rothbauer U; Laufer S
    Methods Mol Biol; 2016; 1360():123-48. PubMed ID: 26501907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Redox/ROS regulation of lipopolysaccharide-induced mitogen-activated protein kinase (MAPK) activation and MAPK-mediated TNF-alpha biosynthesis.
    Haddad JJ; Land SC
    Br J Pharmacol; 2002 Jan; 135(2):520-36. PubMed ID: 11815388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.
    Ho FM; Lai CC; Huang LJ; Kuo TC; Chao CM; Lin WW
    Br J Pharmacol; 2004 Mar; 141(6):1037-47. PubMed ID: 14980980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P4502E1 sensitizes to tumor necrosis factor alpha-induced liver injury through activation of mitogen-activated protein kinases in mice.
    Wu D; Cederbaum A
    Hepatology; 2008 Mar; 47(3):1005-17. PubMed ID: 18095305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The relationship between reactive oxygen species-dependent activation of p38 MAPK and the expression of tumor necrosis factor-α in cultured cardiomyocytes].
    Shang FJ; Wang JP; Zheng QS; Liu XT; Xue YS; Li J; Zhao LY
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):7-10. PubMed ID: 21208554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
    Chen CC; Wang JK
    Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-kappaB and p38 mitogen-activated protein kinase on tumor necrosis factor-alpha production.
    Yamakawa T; Eguchi S; Matsumoto T; Yamakawa Y; Numaguchi K; Miyata I; Reynolds CM; Motley ED; Inagami T
    Endocrinology; 1999 Aug; 140(8):3562-72. PubMed ID: 10433212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxaemia.
    Peng T; Zhang T; Lu X; Feng Q
    Cardiovasc Res; 2009 Mar; 81(4):733-41. PubMed ID: 19043087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils.
    Nick JA; Avdi NJ; Young SK; Lehman LA; McDonald PP; Frasch SC; Billstrom MA; Henson PM; Johnson GL; Worthen GS
    J Clin Invest; 1999 Mar; 103(6):851-8. PubMed ID: 10079106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
    Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
    J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
    Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
    J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p38 MAPK inhibition in nucleus pulposus cells: a potential target for treating intervertebral disc degeneration.
    Studer RK; Aboka AM; Gilbertson LG; Georgescu H; Sowa G; Vo N; Kang JD
    Spine (Phila Pa 1976); 2007 Dec; 32(25):2827-33. PubMed ID: 18246004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of corticosteroid insensitivity by p38 MAPK inhibition in peripheral blood mononuclear cells from COPD.
    Khorasani N; Baker J; Johnson M; Chung KF; Bhavsar PK
    Int J Chron Obstruct Pulmon Dis; 2015; 10():283-91. PubMed ID: 25678784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial endotoxin stimulates macrophages to release HMGB1 partly through CD14- and TNF-dependent mechanisms.
    Chen G; Li J; Ochani M; Rendon-Mitchell B; Qiang X; Susarla S; Ulloa L; Yang H; Fan S; Goyert SM; Wang P; Tracey KJ; Sama AE; Wang H
    J Leukoc Biol; 2004 Nov; 76(5):994-1001. PubMed ID: 15331624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide-induced expression of Th1/Th2 cytokines in whole neonatal cord and adult blood: role of nuclear factor-kappa B and p38 MAPK.
    Koch L; Fritzsching B; Frommhold D; Poeschl J
    Neonatology; 2011; 99(2):140-5. PubMed ID: 20798552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.